Unlock your team's research potential

From pharmaceutical development to cosmetic science, we give researchers the right tools to move faster

Drug Development & Clinical Trials

Accelerate every phase of drug development from target identification to regulatory submission. Analyze competitor clinical trials, identify optimal endpoints, and design robust study protocols.

  • Competitive Intelligence: Analyze competitor clinical trials and publications
  • Protocol Design: Evidence-based endpoint selection and sample size calculations
  • Regulatory Support: Literature reviews for IND/NDA submissions
  • Safety Signals: Monitor adverse event reports across global literature
💊

Pharma Results

50-100x
Faster research
0%
Data used to train AI

Cancer Research & Immunotherapy

🎗️

Oncology Focus

250M+
Papers searchable
12
Academic sources

Stay at the forefront of oncology research. Analyze clinical trials, identify biomarkers, and discover combination therapy opportunities across all cancer types.

  • Biomarker Discovery: Identify predictive and prognostic markers from literature
  • Combination Therapies: Find synergistic treatment opportunities
  • Patient Stratification: Identify subpopulations for targeted trials

Heart Disease & Vascular Studies

Advance cardiovascular research with comprehensive analysis of clinical outcomes, imaging biomarkers, and novel therapeutic targets.

  • Outcome Studies: Analyze MACE endpoints across major cardiovascular trials
  • Risk Factors: Identify emerging cardiovascular risk markers
  • Device Studies: Compare interventional outcomes and techniques
❤️

Cardiology Impact

Comprehensive coverage of cardiovascular literature from ACC, AHA, ESC, and all major cardiology journals worldwide.

Brain Research & Neurological Disorders

🧠

Neuroscience Focus

Access specialized databases for Alzheimer's, Parkinson's, MS, epilepsy, and emerging neurodegenerative disease research.

Navigate the complex landscape of neuroscience research. From Alzheimer's to rare neurological conditions, analyze mechanisms and therapeutic approaches.

  • Disease Mechanisms: Analyze pathophysiology across neurological conditions
  • Cognitive Endpoints: Compare assessment tools and outcome measures
  • Imaging Biomarkers: Track MRI, PET, and other neuroimaging advances

Rare Disease Research

Access specialized rare disease databases including Orphanet, OMIM, and GARD. Find the limited but critical literature for orphan drug development.

  • Orphanet Integration: Access European rare disease reference portal
  • OMIM Database: Genetic disorder information and gene-phenotype relationships
  • Natural History: Compile disease progression data from case reports
🧬

Specialized Databases

Orphanet OMIM GARD ClinicalTrials

Cosmetic & Dermatological Research

Cosmetic Science

Dermatology
Skin research
Safety
Toxicology data

Support cosmetic R&D with scientific evidence. Analyze ingredient efficacy, safety profiles, and dermatological studies for product claims.

  • Ingredient Efficacy: Evidence-based analysis of active ingredients
  • Safety Profiles: Toxicological and sensitization studies
  • Clinical Claims: Support marketing claims with scientific literature
  • Anti-aging Research: Track retinoid, peptide, and antioxidant studies

Frequently Asked Questions

What industries use NousLab?

NousLab is used across pharmaceutical development, oncology, cardiology, neurology, rare disease research, and cosmetic science. Any organization that relies on scientific literature to make decisions can benefit from NousLab, including universities, hospitals, CROs, and biotech companies.

Can NousLab search ClinicalTrials.gov?

Yes. ClinicalTrials.gov is one of the 12 databases NousLab searches. It also includes specialized sources like Orphanet and OMIM for rare disease research, making it particularly useful for drug development and protocol design.

Is NousLab suitable for systematic reviews?

Yes. NousLab was designed with systematic literature reviews in mind. It can search across all major academic databases simultaneously, screen papers by relevance, extract key data points, and help researchers build structured evidence summaries in a fraction of the time required manually.

How much faster is NousLab compared to manual research?

Teams using NousLab report up to 50–100x faster research. Literature reviews that used to take weeks can now be completed in minutes. Protocol design that used to take days takes minutes. The exact time savings depend on the scope of the research question.

Who uses NousLab?

NousLab is built for any organization that relies on scientific literature to make decisions: pharmaceutical companies, biotech and biopharma, CROs, hospitals and teaching centers, medical research centers, MedTech companies, and cosmetic labs. We offer organizational licensing with multi-user access, project management, and enterprise deployment options.

Autonomous research across every industry

Real examples of how research teams use NousLab agents to stay ahead, without manual effort.

💊

Pharma: Literature Review

"A CRO runs the Literature Review agent on 5 drug programs overnight. Monday morning, the team has 75 analyzed papers and 5 structured syntheses, without a single manual search."

🎗️

Oncology: Research Review

"Before a board meeting, the team runs the Research Review agent on their lead hypothesis. It finds 3 contradicting papers published last month and proposes a refined protocol, in 8 minutes."

🏥

Hospital: Monitoring

"A research hospital with 12 active projects gets a weekly digest every Monday. The team knows exactly which 3 projects had high-impact publications, no manual literature watch needed."

Learn more about AI Agents →

Don't See Your Industry?

NousLab works across all scientific disciplines. Contact us to discuss your specific research needs.

Contact Us
AI